Phathom Pharmaceuticals Inc (PHAT)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.44B
EV to revenue ratio (TTM)
1.52
EV to ebitda
-2.20
Financial Performance
Revenue (TTM)
$0.27B
Gross profit (TTM)
$0.22B
EBITDA
-$0.02B
Profitability
Operating margin (TTM)
-0.10%
Profit margin
-30.20%
Return on assets (TTM)
-5.44%
Return on equity (TTM)
-3,489.00%
Per Share Metrics
Revenue per share (TTM)
$3.39
EPS
-$1.01
Diluted EPS (TTM)
-$1.01
Book value
-$4.28
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
5.79
PEG ratio
n/a
Price to sales ratio (TTM)
1.61
Price to book ratio (TTM)
25.37
Growth
Quarterly earnings growth (YoY)
71.10%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
2
Buy
8
Hold
2
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.65